Barker W L
Department of Surgery, University of Illinois College of Medicine, Chicago.
Chest Surg Clin N Am. 1994 Aug;4(3):593-615.
Langston and Sampson point out that the sine qua non of empyema management is early, adequate, and dependent drainage. Diagnostic thoracentesis followed by closed tube thoracostomy and conversion to open drainage, either by a large-bore tube or a rib-resection with a pleurocutaneous fistula, are initial procedures that may be continued for an extended period to control infection, obliterate loculations, and heal co-apted pleural surfaces secondarily. Clagett and Geraci have noted that postpneumonectomy empyema spaces can be "sterilized" and the initial drainage site can be closed after antibiotic instillation. Miller, however, reports success rates for this procedure only in the range of 25% to 33%. Our results are somewhat higher. Obliteration of the persistent space after control of infection by drainage can be accomplished by interposition of muscle flaps with closure of any bronchopleural fistulas and/or by thoracoplasty. As stated previously, myoplastic techniques to obliterate empyemas and close bronchial fistulas in tuberculous disease have a success rate of approximately 75%. Such techniques, however, not only assist in limiting the extent of thoracoplasty, but also may avoid the procedure entirely in some cases. Virkkula has emphasized that use of pedicled myoplasty does not necessarily obviate the need for thoracoplasty. Pairolero and colleagues reported that the use of selected thoracoplasty combined with muscle transposition afforded a 73% success rate for postpneumonectomy empyema and a 64% success rate for closure of persistent bronchopleural fistulas and precludes protracted drainage and/or extended thoracoplasty. Young and Ungerleider concluded that (1) thoracoplasty is more successful if it is applied for patients with parapneumonic rather than postresectional empyemas; (2) concomitant tailoring thoracoplasty has a higher rate of failure; (3) preliminary drainage followed by thoracoplasty has a higher success rate in eliminating the empyema than thoracoplasty alone; (4) first rib resection is indicated for apical collapse only; (5) preoperative preparation is important to control and manage underlying suppurative processes; and (6) thoracoplasty of any type should not be used as a desperation modality of therapy in which uncontrolled sepsis and inadequate drainage are present or in which cancer or unidentified sites of hemorrhage exist. Sequential management of the residual infected space can proceed along several pathways. Many patients with empyema are well-controlled with simple open drainage and with underlying lung reexpansion, either spontaneously or in association with decortication, and may never need thoracoplasty. Drainage and thoracoplasty alone may be effective not only in obliterating an empyema space but also in sealing a bronchopleural fistula.(ABSTRACT TRUNCATED AT 400 WORDS)
兰斯顿和桑普森指出,脓胸治疗的关键在于早期、充分且持续的引流。诊断性胸腔穿刺后行闭式胸腔引流管置入,若需要可转为大口径引流管或行肋骨切除并形成胸膜皮肤瘘的开放引流,这些初始操作可长期进行,以控制感染、消除分隔并促使贴合的胸膜表面愈合。克拉格特和杰拉奇指出,肺切除术后脓腔可通过抗生素注入实现“消毒”,且初始引流部位可关闭。然而,米勒报告该手术的成功率仅在25%至33%之间。我们的结果略高一些。通过插入肌瓣并闭合任何支气管胸膜瘘和/或胸廓成形术,可在通过引流控制感染后消除持续存在的脓腔。如前所述,在结核病中采用肌成形术消除脓胸并闭合支气管瘘的成功率约为75%。然而,此类技术不仅有助于限制胸廓成形术的范围,在某些情况下还可能完全避免该手术。维尔库拉强调,使用带蒂肌成形术不一定能消除胸廓成形术的必要性。派罗勒罗及其同事报告称,采用选择性胸廓成形术联合肌肉移位治疗肺切除术后脓胸的成功率为73%,闭合持续性支气管胸膜瘘的成功率为64%,可避免长期引流和/或广泛的胸廓成形术。扬和昂格尔莱德得出结论:(1)胸廓成形术应用于肺炎旁脓胸患者比应用于切除术后脓胸患者更成功;(2)同期定制胸廓成形术失败率更高;(3)先行引流再行胸廓成形术在消除脓胸方面比单纯胸廓成形术成功率更高;(4)仅在肺尖塌陷时才进行第一肋骨切除;(5)术前准备对于控制和管理潜在的化脓性病变很重要;(6)任何类型的胸廓成形术都不应作为治疗绝望手段,即在存在无法控制的败血症和引流不充分,或存在癌症或不明出血部位的情况下使用。对残留感染腔的序贯管理可通过多种途径进行。许多脓胸患者通过简单的开放引流以及潜在肺组织自发复张或与胸膜剥脱术联合,病情得到良好控制,可能永远不需要胸廓成形术。单纯的引流和胸廓成形术不仅可能有效消除脓腔,还可能封闭支气管胸膜瘘。(摘要截选至400字)